SCHEMBL4143565

SCHEMBL4143565

O=C(O)C1=C(NC(=O)c2ccco2)CCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ RAB9A P51151 4/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ MAPT P10636 3/20 0.58
▸ HPGD P15428 3/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ NPC1 O15118 2/20 0.58
▸ TP53 P04637 2/20 0.58
▸ USP2 O75604 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ PKM P14618 1/20 0.53
▸ TSHR P16473 1/20 0.52
▸ FLT3 P36888 1/20 0.49
▸ HCAR2 Q8TDS4 1/20 0.49
▸ KCNK3 O14649 1/20 0.49
▸ KCNK9 Q9NPC2 1/20 0.49
▸ GFER P55789 1/20 0.49
▸ PTPN2 P17706 1/20 0.49
▸ PTPN1 P18031 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4140119 0.80 ALDH1A1 (0.62) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL4143733 0.72 MEN1 (0.57) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL2997673 0.71 RAB9A (1.00) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL23011774 0.69 ALDH1A1 (0.84) ALDH1A1KMT2ARAB9AMEN1MAPT
Hydrochloric Acid SCHEMBL31228945 0.69 RAB9A (0.96) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL1737866 0.69 — —
SCHEMBL15056399 0.69 RAB9A (0.75) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL18906020 0.69 RAB9A (0.79) ALDH1A1KMT2ARAB9AMEN1SMN1; SMN2
SCHEMBL1843420 0.69 KDM4E (0.52) ALDH1A1RAB9AHPGDSMN1; SMN2NPC1
SCHEMBL1781545 0.69 RAB9A (0.65) ALDH1A1KMT2ARAB9AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 — — US disclosed
EP-1951244-A2 CALCILYTIC COMPOUNDS SmithKline Beecham Corporation (US) 2008-08-06 — — EP disclosed
WO-2007062370-A2 CALCILYTIC COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137557-A1 Calcilytic Compounds CALCR, SOST, CALCB ALDH1A1 4674/4885KMT2A 4875/4885RAB9A 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback